Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.09% |
| 3 | Consumer Staples | 10.57% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
SBA Communications
SBAC
$19.3B
| $106M | 0.09% |
356,949
-676,738
| -65% | -$200M |
|
227
Artisan Partners
APAM
$3.08B
| $106M | 0.09% |
3,269,351
-478,700
| -13% | -$13.3M |
|
228
Casella Waste Systems
CWST
$5.89B
| $105M | 0.09% |
2,023,799
-361,300
| -15% | -$17.2M |
|
229
GE Aerospace
GE
$382B
| $104M | 0.09% |
3,045,070
-5,488,446
| -64% | -$185M |
|
|
IPHI
230
DELISTED
INPHI CORPORATION
IPHI
| $104M | 0.09% |
881,934
+382,800
| +77% | +$40.3M |
|
231
Ionis Pharmaceuticals
IONS
$9.21B
| $103M | 0.09% |
1,752,867
+64,456
| +4% | +$3.59M |
|
232
Bio-Techne
TECH
$11.2B
| $103M | 0.09% |
1,560,700
-386,580
| -20% | -$23.2M |
|
233
Bank of America
BAC
$448B
| $103M | 0.09% |
4,324,066
+3,130,574
| +262% | +$74M |
|
234
Brady Corp
BRC
$4.48B
| $103M | 0.09% |
2,193,140
-170,000
| -7% | -$7.82M |
|
235
Dollar Tree
DLTR
$24.6B
| $102M | 0.09% |
1,105,503
+1,084,703
| +5,215% | +$90.5M |
|
|
MZTI
236
The Marzetti Company
MZTI
$3.15B
| $102M | 0.09% |
660,163
+31,900
| +5% | +$4.64M |
|
237
Autodesk
ADSK
$53.1B
| $101M | 0.09% |
423,868
+231,500
| +120% | +$45.5M |
|
238
Frontdoor
FTDR
$5.76B
| $101M | 0.09% |
2,283,118
+115,600
| +5% | +$4.72M |
|
239
WD-40
WDFC
$3.13B
| $101M | 0.09% |
509,523
+147,100
| +41% | +$26.7M |
|
240
Strategic Education
STRA
$1.81B
| $101M | 0.09% |
657,289
+63,097
| +11% | +$9.84M |
|
241
Eli Lilly
LLY
$1.08T
| $101M | 0.09% |
613,947
+399,347
| +186% | +$61.3M |
|
242
JD.com
JD
$43.1B
| $101M | 0.09% |
1,672,900
+1,641,600
| +5,245% | +$83.1M |
|
243
Upbound Group
UPBD
$1.11B
| $101M | 0.09% |
3,615,224
-571,900
| -14% | -$12.7M |
|
244
Takeda Pharmaceutical
TAK
$55.8B
| $101M | 0.09% |
5,607,700
+1,844,300
| +49% | +$33.1M |
|
245
Portland General Electric
POR
$5.69B
| $100M | 0.09% |
2,400,928
-729,800
| -23% | -$33.4M |
|
|
HUYA
246
Huya Inc
HUYA
$556M
| $100M | 0.09% |
5,373,700
+209,300
| +4% | +$3.49M |
|
247
Murphy USA
MUSA
$10B
| $100M | 0.09% |
890,200
+211,300
| +31% | +$23.1M |
|
248
Progress Software
PRGS
$1.77B
| $99.6M | 0.09% |
2,570,190
+171,600
| +7% | +$6.54M |
|
249
FirstService
FSV
$6.3B
| $99.1M | 0.09% |
983,893
-18,900
| -2% | -$1.68M |
|
250
Honda
HMC
$41.1B
| $98.5M | 0.09% |
3,852,198
+560,400
| +17% | +$13.6M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.